Literature DB >> 27135175

The End-of-Life Experiences of People with Motor Neuron Disease: Family Carers' Perspectives.

Brenda Bentley1, Moira O'Connor2.   

Abstract

BACKGROUND: People with motor neuron disease (MND) face barriers when accessing palliative care. There is a lack of research about how these barriers affect the end-of-life (EOL) and death experiences of people with MND. AIM: This study examined the perceptions of EOL experiences of family carers of people with MND in Western Australia (WA) to identify unmet needs and gaps in EOL support for people with MND and their family carers.
DESIGN: Semistructured interviews were conducted with 12 bereaved family carers of people who died from MND in WA. Thematic analysis was used to identify common themes.
RESULTS: The themes identified can be summarized into three main areas: accessing support, accessing information, and feeling prepared.
CONCLUSIONS: The findings indicate that increased access to specialist palliative care services by people with MND is needed to improve EOL experiences.

Entities:  

Mesh:

Year:  2016        PMID: 27135175     DOI: 10.1089/jpm.2015.0538

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  3 in total

1.  Comparison of the experience of caregiving at end of life or in hastened death: a narrative synthesis review.

Authors:  Jane Lowers; Melissa Scardaville; Sean Hughes; Nancy J Preston
Journal:  BMC Palliat Care       Date:  2020-10-08       Impact factor: 3.234

Review 2.  End of life care for long-term neurological conditions: A meta-ethnographic review of the experiences of informal carers.

Authors:  Michael Toze; Mo Ray; Thomas George; Kelly Sisson; David Nelson
Journal:  Palliat Med       Date:  2020-11-25       Impact factor: 4.762

3.  The experiences of, and need for, palliative care for people with motor neurone disease and their informal caregivers: A qualitative systematic review.

Authors:  Kate Flemming; Victoria Turner; Samantha Bolsher; Bill Hulme; Elizabeth McHugh; Ian Watt
Journal:  Palliat Med       Date:  2020-04-14       Impact factor: 4.762

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.